Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix structural constituent	THSD4 FRAS1 VTN COL6A5 MEPE VCAN FGA NID1 MUC4	1.83e-05	188	157	9	GO:0005201
GeneOntologyMolecularFunction	cell adhesion molecule binding	FLNB VTN CDHR5 ITGA2 ITGB6 PTPN11 TJP1 PTPRZ1 CGN CD40LG FGA IZUMO1 BCAM CNTN2 CDH13	7.91e-05	599	157	15	GO:0050839
GeneOntologyBiologicalProcess	NLS-bearing protein import into nucleus	RANBP2 RGPD8 RGPD1 RGPD5	1.53e-05	20	160	4	GO:0006607
GeneOntologyBiologicalProcess	positive regulation of glucokinase activity	RANBP2 RGPD8 RGPD1	3.72e-05	9	160	3	GO:0033133
GeneOntologyBiologicalProcess	cell morphogenesis	FLNB PLOD3 ALS2 ZSWIM6 SLC30A1 JMJD1C ITGB6 ANKRD27 WDR47 YTHDF1 PTPN11 KIDINS220 PTPRZ1 TET1 CGN CAPRIN2 LRP6 CFAP70 POTEJ CNTN2 CDH13 TBCE SMAD4	5.00e-05	1194	160	23	GO:0000902
GeneOntologyBiologicalProcess	cell-matrix adhesion	VTN ITGA2 ITGB6 PTPN11 FGA NID1 BCAM MUC4 CNTN2 CDH13	5.08e-05	270	160	10	GO:0007160
GeneOntologyBiologicalProcess	positive regulation of hexokinase activity	RANBP2 RGPD8 RGPD1	5.28e-05	10	160	3	GO:1903301
GeneOntologyCellularComponent	nuclear inclusion body	RANBP2 RGPD8 RGPD1 ATXN1	1.39e-05	20	158	4	GO:0042405
GeneOntologyCellularComponent	cytoplasmic periphery of the nuclear pore complex	RANBP2 RGPD8 RGPD1	2.31e-05	8	158	3	GO:1990723
GeneOntologyCellularComponent	extracellular matrix	THSD4 FRAS1 IL16 VTN PLOD3 COL6A5 MEPE OTOGL PTPRZ1 SULF1 VCAN FGA NID1 BCAM MUC4 CDH13	3.90e-05	656	158	16	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	THSD4 FRAS1 IL16 VTN PLOD3 COL6A5 MEPE OTOGL PTPRZ1 SULF1 VCAN FGA NID1 BCAM MUC4 CDH13	4.04e-05	658	158	16	GO:0030312
GeneOntologyCellularComponent	nuclear pore cytoplasmic filaments	RANBP2 RGPD8 RGPD1	4.89e-05	10	158	3	GO:0044614
GeneOntologyCellularComponent	collagen-containing extracellular matrix	THSD4 FRAS1 IL16 VTN PLOD3 COL6A5 PTPRZ1 SULF1 VCAN FGA NID1 BCAM MUC4 CDH13	5.20e-05	530	158	14	GO:0062023
GeneOntologyCellularComponent	protein complex involved in cell adhesion	VTN ITGA2 ITGB6 IZUMO1 NID1	8.34e-05	59	158	5	GO:0098636
GeneOntologyCellularComponent	annulate lamellae	RANBP2 RGPD8 RGPD1	1.45e-04	14	158	3	GO:0005642
GeneOntologyCellularComponent	nuclear pore nuclear basket	RANBP2 RGPD8 RGPD1	3.18e-04	18	158	3	GO:0044615
GeneOntologyCellularComponent	SUMO ligase complex	RANBP2 RGPD8 RGPD1	5.10e-04	21	158	3	GO:0106068
GeneOntologyCellularComponent	nuclear pore	RANBP2 RGPD8 RGPD1 POM121L2 RGPD5	1.02e-03	101	158	5	GO:0005643
Domain	Ran_BP1	RANBP2 RGPD8 RGPD1 RGPD5	2.37e-06	12	159	4	PF00638
Domain	RANBD1	RANBP2 RGPD8 RGPD1 RGPD5	2.37e-06	12	159	4	PS50196
Domain	RanBD	RANBP2 RGPD8 RGPD1 RGPD5	3.41e-06	13	159	4	SM00160
Domain	Ran_bind_dom	RANBP2 RGPD8 RGPD1 RGPD5	3.41e-06	13	159	4	IPR000156
Domain	Grip	RGPD8 RGPD1 RGPD5	9.50e-05	11	159	3	SM00755
Domain	GRIP	RGPD8 RGPD1 RGPD5	9.50e-05	11	159	3	PF01465
Domain	GRIP_dom	RGPD8 RGPD1 RGPD5	1.26e-04	12	159	3	IPR000237
Domain	GRIP	RGPD8 RGPD1 RGPD5	1.26e-04	12	159	3	PS50913
Domain	ZU5	MACC1 ANK1 TJP1	1.26e-04	12	159	3	PF00791
Domain	ZU5_dom	MACC1 ANK1 TJP1	1.26e-04	12	159	3	IPR000906
Domain	DUF4211	PRR12 QSER1	2.15e-04	3	159	2	PF13926
Domain	DUF4211	PRR12 QSER1	2.15e-04	3	159	2	IPR025451
Domain	WD40	WSB2 WDFY4 EML3 WDR53 SHKBP1 WDR47 WDR97 KCTD3 WDR90	4.93e-04	268	159	9	SM00320
Domain	WD40_repeat_CS	WSB2 WDFY4 WDR53 WDR47 WDR97 KCTD3 WDR90	5.17e-04	164	159	7	IPR019775
Domain	WD40_repeat	WSB2 WDFY4 EML3 WDR53 SHKBP1 WDR47 WDR97 KCTD3 WDR90	5.49e-04	272	159	9	IPR001680
Domain	WD_REPEATS_1	WSB2 WDFY4 EML3 WDR53 SHKBP1 WDR47 WDR97 KCTD3 WDR90	6.42e-04	278	159	9	PS00678
Domain	WD_REPEATS_2	WSB2 WDFY4 EML3 WDR53 SHKBP1 WDR47 WDR97 KCTD3 WDR90	6.58e-04	279	159	9	PS50082
Domain	WD_REPEATS_REGION	WSB2 WDFY4 EML3 WDR53 SHKBP1 WDR47 WDR97 KCTD3 WDR90	6.58e-04	279	159	9	PS50294
Domain	NIDO_dom	NID1 MUC4	7.08e-04	5	159	2	IPR003886
Domain	NIDO	NID1 MUC4	7.08e-04	5	159	2	SM00539
Domain	NIDO	NID1 MUC4	7.08e-04	5	159	2	PF06119
Domain	NIDO	NID1 MUC4	7.08e-04	5	159	2	PS51220
Pathway	BIOCARTA_RANBP2_PATHWAY	RANBP2 HDAC5 RGPD8 RGPD1	9.87e-06	18	110	4	MM1549
Pathway	REACTOME_ECM_PROTEOGLYCANS	VTN COL6A5 ITGA2 ITGB6 VCAN	3.12e-05	47	110	5	MM14925
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	UNC13B ZHX3 FRAS1 HDAC5 LRCH2 SPEG GON4L ALS2 ZSWIM6 WDR47 KIDINS220 STARD9 NFAT5	8.51e-08	407	165	13	12693553
Pubmed	Identification of a novel Ran binding protein 2 related gene (RANBP2L1) and detection of a gene cluster on human chromosome 2q11-q12.	RANBP2 RGPD8 RGPD5	4.18e-07	4	165	3	9480752
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	FLNB RANBP2 NDUFS7 HDAC5 RGPD8 RGPD1 IDH3A JMJD1C PRR12 N4BP2 TET1 TAF1	8.39e-07	418	165	12	34709266
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	FRAS1 IL16 VTN PLOD3 COL6A5 VCAN FGA NID1	1.45e-06	167	165	8	22159717
Pubmed	Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo.	VTA1 PTPN11 IZUMO1 FUT2	1.79e-06	19	165	4	21060863
Pubmed	Interconversion of red opsin isoforms by the cyclophilin-related chaperone protein Ran-binding protein 2.	RANBP2 RGPD8 RGPD1	3.62e-06	7	165	3	9037092
Pubmed	Complex genomic rearrangements lead to novel primate gene function.	RGPD8 RGPD1 RGPD5	3.62e-06	7	165	3	15710750
Pubmed	Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene.	RANBP2 RGPD8 RGPD1	3.62e-06	7	165	3	11353387
Pubmed	Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons.	RANBP2 RGPD8 RGPD1	3.62e-06	7	165	3	30944974
Pubmed	Nucleoporin Nup358 drives the differentiation of myeloid-biased multipotent progenitors by modulating HDAC3 nuclear translocation.	RANBP2 RGPD8 RGPD1	3.62e-06	7	165	3	38838144
Pubmed	Retina-specifically expressed novel subtypes of bovine cyclophilin.	RANBP2 RGPD8 RGPD1	3.62e-06	7	165	3	7559465
Pubmed	Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate.	RANBP2 RGPD8 RGPD1	3.62e-06	7	165	3	17372272
Pubmed	Proteostatic Remodeling of Small Heat Shock Chaperones─Crystallins by Ran-Binding Protein 2─and the Peptidyl-Prolyl cis-trans Isomerase and Chaperone Activities of Its Cyclophilin Domain.	RANBP2 RGPD8 RGPD1	3.62e-06	7	165	3	38657106
Pubmed	Nup358, a nucleoporin, functions as a key determinant of the nuclear pore complex structure remodeling during skeletal myogenesis.	RANBP2 RGPD8 RGPD1	3.62e-06	7	165	3	21205196
Pubmed	Haploinsufficiency of RanBP2 is neuroprotective against light-elicited and age-dependent degeneration of photoreceptor neurons.	RANBP2 RGPD8 RGPD1	3.62e-06	7	165	3	18949001
Pubmed	Selective impairment of a subset of Ran-GTP-binding domains of ran-binding protein 2 (Ranbp2) suffices to recapitulate the degeneration of the retinal pigment epithelium (RPE) triggered by Ranbp2 ablation.	RANBP2 RGPD8 RGPD1	3.62e-06	7	165	3	25187515
Pubmed	Localization of the Ran-GTP binding protein RanBP2 at the cytoplasmic side of the nuclear pore complex.	RANBP2 RGPD8 RGPD1	3.62e-06	7	165	3	8603673
Pubmed	Uncoupling phototoxicity-elicited neural dysmorphology and death by insidious function and selective impairment of Ran-binding protein 2 (Ranbp2).	RANBP2 RGPD8 RGPD1	3.62e-06	7	165	3	26632511
Pubmed	Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.	RANBP2 RGPD8 RGPD1	3.62e-06	7	165	3	24403063
Pubmed	Distinct and atypical intrinsic and extrinsic cell death pathways between photoreceptor cell types upon specific ablation of Ranbp2 in cone photoreceptors.	RANBP2 RGPD8 RGPD1	3.62e-06	7	165	3	23818861
Pubmed	Kinesin-1 and mitochondrial motility control by discrimination of structurally equivalent but distinct subdomains in Ran-GTP-binding domains of Ran-binding protein 2.	RANBP2 RGPD8 RGPD1	3.62e-06	7	165	3	23536549
Pubmed	Identification of RanBP2- and kinesin-mediated transport pathways with restricted neuronal and subcellular localization.	RANBP2 RGPD8 RGPD1	3.62e-06	7	165	3	12191015
Pubmed	Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).	RANBP2 RGPD8 RGPD1	3.62e-06	7	165	3	22821000
Pubmed	Neuroprotection resulting from insufficiency of RANBP2 is associated with the modulation of protein and lipid homeostasis of functionally diverse but linked pathways in response to oxidative stress.	RANBP2 RGPD8 RGPD1	3.62e-06	7	165	3	20682751
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	CELF5 ZHX3 PLOD3 ANK1 SPEG SCAF4 GTF2F2 FGA NID1 IGLL1 MUC4 HYDIN	4.98e-06	497	165	12	36774506
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	HDAC5 GON4L ITGA2 SIRT6 CPS1 MAST2 EML3 SDR39U1 NCOA5 PTPN11 TJP1 SULF1 VCAN CGN FGA CPXM1 NID1 CNTN2 CDH13	5.57e-06	1215	165	19	15146197
Pubmed	The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity.	RANBP2 RGPD8 RGPD1	5.77e-06	8	165	3	21670213
Pubmed	Critical role of RanBP2-mediated SUMOylation of Small Heterodimer Partner in maintaining bile acid homeostasis.	RANBP2 RGPD8 RGPD1	5.77e-06	8	165	3	27412403
Pubmed	Mice lacking Ran binding protein 1 are viable and show male infertility.	RANBP2 RGPD8 RGPD1	5.77e-06	8	165	3	21310149
Pubmed	The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2.	RANBP2 RGPD8 RGPD1	5.77e-06	8	165	3	22262462
Pubmed	Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes.	RANBP2 RGPD8 RGPD1	5.77e-06	8	165	3	28745977
Pubmed	Interaction network of human early embryonic transcription factors.	RANBP2 HDAC5 RGPD1 PRR12 ATXN1 TET1 PAXIP1 TAF1 QSER1 SLX4	7.55e-06	351	165	10	38297188
Pubmed	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.	RANBP2 RGPD8 RGPD1	8.63e-06	9	165	3	18394993
Pubmed	Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes.	RANBP2 RGPD8 RGPD1	8.63e-06	9	165	3	28100513
Pubmed	Association of the kinesin-binding domain of RanBP2 to KIF5B and KIF5C determines mitochondria localization and function.	RANBP2 RGPD8 RGPD1	8.63e-06	9	165	3	17887960
Pubmed	The docking of kinesins, KIF5B and KIF5C, to Ran-binding protein 2 (RanBP2) is mediated via a novel RanBP2 domain.	RANBP2 RGPD8 RGPD1	8.63e-06	9	165	3	11553612
Pubmed	The zinc finger cluster domain of RanBP2 is a specific docking site for the nuclear export factor, exportin-1.	RANBP2 RGPD8 RGPD1	8.63e-06	9	165	3	10601307
Pubmed	The cyclophilin-like domain mediates the association of Ran-binding protein 2 with subunits of the 19 S regulatory complex of the proteasome.	RANBP2 RGPD8 RGPD1	8.63e-06	9	165	3	9733766
Pubmed	Impairments in age-dependent ubiquitin proteostasis and structural integrity of selective neurons by uncoupling Ran GTPase from the Ran-binding domain 3 of Ranbp2 and identification of novel mitochondrial isoforms of ubiquitin-conjugating enzyme E2I (ubc9) and Ranbp2.	RANBP2 RGPD8 RGPD1	8.63e-06	9	165	3	28877029
Pubmed	The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.	RANBP2 RGPD8 RGPD1	1.23e-05	10	165	3	27160050
Pubmed	Parkin ubiquitinates and promotes the degradation of RanBP2.	RANBP2 RGPD8 RGPD1	1.23e-05	10	165	3	16332688
Pubmed	Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin.	RANBP2 RGPD8 RGPD1	1.23e-05	10	165	3	8857542
Pubmed	Ran-dependent docking of importin-beta to RanBP2/Nup358 filaments is essential for protein import and cell viability.	RANBP2 RGPD8 RGPD1	1.23e-05	10	165	3	21859863
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	FRAS1 VTN COL6A5 VCAN NID1	1.38e-05	64	165	5	22261194
Pubmed	RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism.	RANBP2 RGPD8 RGPD1	1.68e-05	11	165	3	17069463
Pubmed	Atypical Cadherin Fat1 Is Required for Lens Epithelial Cell Polarity and Proliferation but Not for Fiber Differentiation.	FAT4 TJP1 MIP	1.68e-05	11	165	3	26114487
Pubmed	An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age.	RANBP2 RGPD8 RGPD1	1.68e-05	11	165	3	35771867
Pubmed	T-cell receptor (TCR) signaling promotes the assembly of RanBP2/RanGAP1-SUMO1/Ubc9 nuclear pore subcomplex via PKC-θ-mediated phosphorylation of RanGAP1.	RANBP2 RGPD8 RGPD1	1.68e-05	11	165	3	34110283
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	FLNB SDK2 RGPD8 GON4L MAST2 OGDH EFTUD2 DHX15	1.73e-05	234	165	8	36243803
Pubmed	Human variation in alcohol response is influenced by variation in neuronal signaling genes.	PDE4D ITGA2 ADRB2 PTPRZ1 VCAN CDH13 TBCE	1.86e-05	171	165	7	20201926
Pubmed	Differential association of phosphodiesterase 4D isoforms with beta2-adrenoceptor in cardiac myocytes.	PDE4D ADRB2	2.24e-05	2	165	2	19801680
Pubmed	N-ethylmaleimide-sensitive factor regulates beta2 adrenoceptor trafficking and signaling in cardiomyocytes.	NSF ADRB2	2.24e-05	2	165	2	17510209
Pubmed	Vitronectin, a Novel Urinary Proteomic Biomarker, Promotes Cell Pyroptosis in Juvenile Systemic Lupus Erythematosus.	VTN NLRP3	2.24e-05	2	165	2	35462789
Pubmed	A major functional role for phosphodiesterase 4D5 in human airway smooth muscle cells.	PDE4D ADRB2	2.24e-05	2	165	2	17673687
Pubmed	Siglec-6 Signaling Uses Src Kinase Tyrosine Phosphorylation and SHP-2 Recruitment.	PTPN11 SIGLEC6	2.24e-05	2	165	2	36359823
Pubmed	Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.	MUC16 MUC4	2.24e-05	2	165	2	23544943
Pubmed	Epithelial differentiation and intercellular junction formation in the mouse early embryo.	TJP1 CGN	2.24e-05	2	165	2	1299356
Pubmed	ADAR3 alleviated inflammation and pyroptosis of neuropathic pain by targeting NLRP3 in chronic constriction injury mice.	ADARB2 NLRP3	2.24e-05	2	165	2	34419568
Pubmed	RNA m6A reader YTHDF1 facilitates inflammation via enhancing NLRP3 translation.	NLRP3 YTHDF1	2.24e-05	2	165	2	35649302
Pubmed	Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease.	CPS1 JMJD1C NLRP3 FGA	2.28e-05	35	165	4	23969696
Pubmed	Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons.	RANBP2 RGPD8 RGPD1	2.90e-05	13	165	3	31427429
Pubmed	Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).	THSD4 ATP6V1B1 GBP6 VTN PLOD3 MUC16 VTA1 BMP3 FUT2 MUC4	3.31e-05	417	165	10	19199708
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	FAT4 FRAS1 PLOD3 RGPD8 EFTUD2 DHX15 PRR12 STARD9 NID1 TNFRSF19 DSE	3.70e-05	513	165	11	25798074
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	ZHX3 JMJD1C MED24 PRR12 ATXN1 PAXIP1 TAF1 QSER1	4.53e-05	268	165	8	33640491
Pubmed	Limited expression of nuclear pore membrane glycoprotein 210 in cell lines and tissues suggests cell-type specific nuclear pores in metazoans.	RANBP2 RGPD8 RGPD1	4.58e-05	15	165	3	14697343
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	UNC13B DMGDH CPAMD8 EXO5 GALNS INHBC ALS2 ITGA2 CPS1 SLC22A18 ATXN1 VCAN CGN LRP6 TAF1 BCAM HYDIN INVS	4.61e-05	1293	165	18	15342556
Pubmed	The type I BMP receptors, Bmpr1a and Acvr1, activate multiple signaling pathways to regulate lens formation.	TJP1 NID1 SMAD4	5.61e-05	16	165	3	19733164
Pubmed	Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.	GBP6 ZNF366 GON4L VTA1 IQCN MTMR10 ITGB6 ANKRD27 SULF1 ARNT2 RAB39B RNF180 RGPD5	6.50e-05	750	165	13	11230166
Pubmed	Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.	MUC16 MUC4	6.69e-05	3	165	2	23053434
Pubmed	β2-adrenergic receptor-coupled phosphoinositide 3-kinase constrains cAMP-dependent increases in cardiac inotropy through phosphodiesterase 4 activation.	PDE4D ADRB2	6.69e-05	3	165	2	20705779
Pubmed	Potential role of entactin in hemostasis. Specific interaction of entactin with fibrinogen A alpha and B beta chains.	FGA NID1	6.69e-05	3	165	2	1680863
Pubmed	Identification of new interacting partners of the shuttling protein ubinuclein (Ubn-1).	TJP1 CGN	6.69e-05	3	165	2	22245583
Pubmed	Sex-specific association of rs16996148 SNP in the NCAN/CILP2/PBX4 and serum lipid levels in the Mulao and Han populations.	PBX4 CILP2	6.69e-05	3	165	2	22208664
Pubmed	Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.	MUC16 MUC4	6.69e-05	3	165	2	30236127
Pubmed	HDAC5 RNA interference ameliorates acute renal injury by upregulating KLF2 and inhibiting NALP3 expression in a mouse model of oxalate nephropathy.	HDAC5 NLRP3	6.69e-05	3	165	2	36183679
Pubmed	The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosine.	SIRT6 TET1	6.69e-05	3	165	2	25915124
Pubmed	Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).	MUC16 MUC4	6.69e-05	3	165	2	27483328
Pubmed	MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer.	MUC16 MUC4	6.69e-05	3	165	2	24204560
Pubmed	Human and Xenopus cingulin share a modular organization of the coiled-coil rod domain: predictions for intra- and intermolecular assembly.	TJP1 CGN	6.69e-05	3	165	2	11042084
Pubmed	Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.	MUC16 MUC4	6.69e-05	3	165	2	24939955
Pubmed	Signaling from beta1- and beta2-adrenergic receptors is defined by differential interactions with PDE4.	PDE4D ADRB2	6.69e-05	3	165	2	18188154
Pubmed	Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes.	ADRB2 SMAD4	6.69e-05	3	165	2	9506519
Pubmed	Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone.	MUC16 MUC4	6.69e-05	3	165	2	17592322
Pubmed	Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection.	MUC16 MUC4	6.69e-05	3	165	2	35879412
Pubmed	Evidence for a functional interaction between cingulin and ZO-1 in cultured cells.	TJP1 CGN	6.69e-05	3	165	2	12023291
Pubmed	Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.	UNC13B NSF	6.69e-05	3	165	2	21812969
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	RANBP2 ZBTB2 RGPD8 RGPD1 TET1 QSER1	7.30e-05	146	165	6	23892456
Pubmed	Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations.	IL16 NCKAP5 ADRB2 CDH13	7.43e-05	47	165	4	18821565
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	FLNB RANBP2 PLOD3 RGPD8 NSF RGPD1 IDH3A OGDH JMJD1C EFTUD2 DHX15 ATXN1	8.57e-05	665	165	12	30457570
Pubmed	An integrated genetic map of the pearl locus of mouse chromosome 13.	PDE4D ITGA2 VCAN	9.61e-05	19	165	3	8828042
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	FLNB RANBP2 RPN2 RADX SHKBP1 EFTUD2 DHX15 CILP2 CGN KCTD3	1.01e-04	477	165	10	31300519
Pubmed	Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation.	VTN VCAN NID1 BCAM CDH13	1.02e-04	97	165	5	27559042
Pubmed	Proteomic and yeast 2-hybrid screens to identify PTEN binding partners.	RANBP2 RGPD8 RGPD1 ITGA2 IDH3A EFTUD2 TJP1	1.09e-04	226	165	7	37839992
Pubmed	Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.	PLOD3 LRCH2 RGPD1 EFTUD2 DHX15 MED24 GTF2F2 FGA TAF1	1.10e-04	390	165	9	17643375
Pubmed	Insights into specificity, redundancy and new cellular functions of C/EBPa and C/EBPb transcription factors through interactome network analysis.	RANBP2 RGPD8 RGPD1 JMJD1C MUC4	1.13e-04	99	165	5	27746211
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	GON4L ALS2 ZSWIM6 WDFY4 NCOA5	1.24e-04	101	165	5	10997877
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	RANBP2 ANK1 RGPD8 SPEG RGPD1 PTPRZ1 FGA	1.24e-04	231	165	7	16452087
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZBTB2 WDFY4 JMJD1C SCAF4 EFTUD2 NCOA5 PRR12 N4BP2 CGN SLX4	1.32e-04	493	165	10	15368895
Pubmed	Crosstalk Between RPE Cells and Choroidal Endothelial Cells via the ANXA1/FPR2/SHP2/NLRP3 Inflammasome/Pyroptosis Axis Promotes Choroidal Neovascularization.	NLRP3 PTPN11	1.33e-04	4	165	2	34595678
Pubmed	Integrin alphavbeta6 mediates HT29-D4 cell adhesion to MMP-processed fibrinogen in the presence of Mn2+.	ITGB6 FGA	1.33e-04	4	165	2	17275949
GeneFamily	WD repeat domain containing	WSB2 WDFY4 EML3 WDR53 SHKBP1 WDR47 WDR97 WDR90	3.06e-04	262	117	8	362
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	RANBP2 RGPD8 RGPD1 CFAP70 RGPD5	9.07e-04	115	117	5	769
Coexpression	LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET	THSD4 RANBP2 MACC1 FRAS1 PDE4D ZSWIM6 ITGA2 JMJD1C ATXN1 TJP1 NFAT5	3.40e-07	240	163	11	M39236
Coexpression	NABA_CORE_MATRISOME	THSD4 FRAS1 VTN COL6A5 MEPE CILP2 OTOGL VCAN FGA NID1	7.87e-06	270	163	10	MM17057
Coexpression	WANG_SMARCE1_TARGETS_UP	FRAS1 PCDHB10 ITGA2 ATXN1 SULF1 VCAN NID1 ATP11C TNFRSF19 BCAM	1.65e-05	294	163	10	M1804
Coexpression	KOYAMA_SEMA3B_TARGETS_DN	GALNS GON4L ALS2 NLRP3 PTPN11 CGN PAXIP1 ATP11C QSER1 NFAT5 TBCE	1.86e-05	364	163	11	M2029
Coexpression	NABA_ECM_GLYCOPROTEINS	THSD4 FRAS1 VTN MEPE CILP2 OTOGL FGA NID1	2.72e-05	191	163	8	MM17059
Coexpression	GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN	ZHX3 NLRP3 ADRB2 TET1 CCDC15 ATP11C DSE	3.40e-05	144	163	7	M335
Coexpression	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP	INHBC ITGB6 MEPE NRARP LPAR6 PI4KB FUT2 SLX4	3.52e-05	198	163	8	M9829
Coexpression	GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP	CERK GBP6 PBX4 ALS2 EML3 ATXN1 DSE INVS	3.65e-05	199	163	8	M5687
Coexpression	HE_LIM_SUN_FETAL_LUNG_C6_MUC16_POS_CILIATED_CELL	GBP6 MUC16 ITGA2 VCAN MUC4	4.25e-05	62	163	5	M45790
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	ESS2 LRCH2 VCAN RAB39B	5.78e-05	34	163	4	M11023
Coexpression	NABA_CORE_MATRISOME	THSD4 FRAS1 VTN COL6A5 MEPE CILP2 VCAN FGA NID1	5.92e-05	275	163	9	M5884
Coexpression	NABA_MATRISOME	THSD4 FRAS1 IL16 VTN PLOD3 INHBC MUC16 COL6A5 MEPE BMP3 CILP2 SERPINB13 OTOGL SULF1 VCAN FGA NID1 MUC4	5.95e-05	1008	163	18	MM17056
Coexpression	YAGUE_PRETUMOR_DRUG_RESISTANCE_DN	VCAN TNS1 DSE	6.45e-05	13	163	3	M2070
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	ESS2 LRCH2 VCAN RAB39B	7.27e-05	36	163	4	MM486
Coexpression	NABA_MATRISOME	THSD4 CPAMD8 FRAS1 IL16 VTN PLOD3 INHBC MUC16 COL6A5 MEPE BMP3 CILP2 SERPINB13 SULF1 VCAN FGA NID1 MUC4	7.45e-05	1026	163	18	M5889
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA1	PCSK2 CELF5 FAT4 PDE4D ANK1 ZSWIM6 MAST2 SEZ6L2 ADARB2 WDR47 ATP11C BICRAL CDH13	7.82e-05	584	163	13	M39068
Coexpression	HEBERT_MATRISOME_TNBC_LIVER_METASTASIS	VTN COL6A5 FGA	8.17e-05	14	163	3	M48002
Coexpression	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	THSD4 PDE4D ZSWIM6 ITGA2 ATXN1 LPAR6 PI4KB SLC24A1	8.92e-05	226	163	8	M11238
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 PCDHB10 ITGA2 SEZ6L2 NRARP PRDM10 SULF1 BCAM CDH13	1.53e-08	170	165	9	50c6c571591aa4b218caefe5778c570c809f567e
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 PCDHB10 ITGA2 SEZ6L2 NRARP PRDM10 SULF1 BCAM CDH13	1.53e-08	170	165	9	8fe32dcf924d5f6665f7febbc9647d96b1e96f06
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 PCDHB10 ITGA2 SEZ6L2 NRARP PRDM10 SULF1 BCAM CDH13	1.53e-08	170	165	9	3232db50b1a40f861e981a1b9c9073b81af9f832
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FRAS1 NCKAP5 ITGA2 SERPINB13 PTPRZ1 BCAM MUC4 TNS1 CDH13	5.97e-08	199	165	9	94a7867e800df352731796de8c24cba133c29622
ToppCell	Control-Epithelial_cells-Airway_basal\|Control / group, cell type (main and fine annotations)	FRAS1 ITGA2 ADARB2 SERPINB13 PTPRZ1 SULF1 BCAM MUC4	2.55e-07	171	165	8	3965ced4be6db14265a90673502fceee425837ca
ToppCell	cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GBP6 MUC16 ITGA2 NRARP SERPINB13 PTPRZ1 FUT2 MUC4	7.76e-07	198	165	8	6e047de63ef59dcb47e4fc06b173b2a02fdcf4c9
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZSWIM6 JMJD1C NLRP3 CILP2 VCAN SLX4 DSE	1.08e-06	143	165	7	7adc34d8ad11e57950a5a258ae9bf8f52259385a
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCSK2 EXO5 EML3 MMADHC SULF1 TET1 MFSD13A	2.29e-06	160	165	7	778faada072e3abfa76a9a06fd4885fb63de7902
ToppCell	nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ATP6V1B1 MUC16 ADARB2 NRARP SERPINB13 PTPRZ1 FUT2	2.48e-06	162	165	7	112fa4de685727f6c8bf6fc4afb82de0524070ad
ToppCell	nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ITGA2 ADARB2 SERPINB13 PTPRZ1 SULF1 BCAM MUC4	4.46e-06	177	165	7	cbad1a23851151dbef01ea2af960e6f0944f838b
ToppCell	nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ITGA2 ADARB2 SERPINB13 PTPRZ1 SULF1 BCAM MUC4	4.46e-06	177	165	7	ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LRCH2 NCKAP5 ADARB2 TJP1 STARD9 NID1 TNS1	4.63e-06	178	165	7	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCSK2 FAT4 SDK2 OVOS2 NCKAP5 SEZ6L2 ADARB2	4.80e-06	179	165	7	c7afbd10072d36a35cd20ae73670d76b9cefd22d
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MACC1 FRAS1 ITGA2 ITGB6 CGN BCAM CDH13	4.80e-06	179	165	7	04ce3673e46606f63d9c87bcba3a64c96817d812
ToppCell	5'-Adult-Appendix-Neuronal-Glial_mature\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FRAS1 PCDHGB2 SEZ6L2 ADARB2 PTPRZ1 ARNT2 CNTN2	5.16e-06	181	165	7	3aa81ac64d0cc9a74fbfa71e2176740548e7cd06
ToppCell	5'-Adult-Appendix-Neuronal-Glial_mature-Adult_Glia\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FRAS1 PCDHGB2 SEZ6L2 ADARB2 PTPRZ1 ARNT2 CNTN2	5.16e-06	181	165	7	997ba1be2824b00d684f2163d0114656ed11fa53
ToppCell	5'-Adult-Appendix-Neuronal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FRAS1 PCDHGB2 SEZ6L2 ADARB2 PTPRZ1 ARNT2 CNTN2	5.16e-06	181	165	7	e6b7e8dd5c13cc10ba22f2f5a8c669486f934bdc
ToppCell	COVID-19-Epithelial_cells-ECM-high_epithelial\|COVID-19 / group, cell type (main and fine annotations)	UNC13B THSD4 FLNB PDE4D NCKAP5 ITGA2 ITGB6	5.55e-06	183	165	7	dc1d380bf7564f290256cb7108063d1bd2da732b
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 FRAS1 ANK1 CPS1 OTOGL HYDIN CNTN2	5.75e-06	184	165	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 FRAS1 ANK1 CPS1 OTOGL HYDIN CNTN2	5.75e-06	184	165	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 FRAS1 ANK1 CPS1 OTOGL HYDIN CNTN2	5.75e-06	184	165	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCSK2 FAT4 SDK2 OVOS2 NCKAP5 SEZ6L2 ADARB2	5.96e-06	185	165	7	16e9ccea0e3b95d90dc48ef74206c805681dac0b
ToppCell	Tuft\|World / Class top	FLNB IL16 ANK1 SEZ6L2 MYDGF CDH13 IL17RB	6.17e-06	186	165	7	f4d83f15ab7b49c0920a322cd832413ece7c9948
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MACC1 FRAS1 SDK2 ITGA2 ITGB6 CGN BCAM	6.40e-06	187	165	7	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	Tuft-tuft-2\|World / Class top	FLNB IL16 ANK1 SEZ6L2 MYDGF CDH13 IL17RB	6.40e-06	187	165	7	4ec6eee866619dfe13c84f5d2e812bb380d37139
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	PDE4D ITGA2 ADARB2 SERPINB13 PTPRZ1 BCAM MUC4	6.40e-06	187	165	7	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	15-Airway-Epithelial-Basal_cell\|Airway / Age, Tissue, Lineage and Cell class	FRAS1 ITGA2 ITGB6 BMP3 ADRB2 PTPRZ1 BCAM	6.86e-06	189	165	7	f128c2fc37f232d193de18a922c47fdd70e1982d
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	FRAS1 PDE4D VCAN LRP6 TNFRSF19 NFAT5 IL17RB	7.60e-06	192	165	7	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 MACC1 FRAS1 PDE4D UGT3A1 MTMR10 BCAM	7.60e-06	192	165	7	9e031bf93eb8757fdd0cc22f01b44e48f85532d5
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 MACC1 FRAS1 PDE4D UGT3A1 MTMR10 BCAM	7.60e-06	192	165	7	3d777d07878269b87ec7e1f06489cae7c989d633
ToppCell	367C-Myeloid-Dendritic-cDC_activated\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	VTN MOSPD2 ZNF366 OVOS2 ARNT2 ATP11C RNF180	7.60e-06	192	165	7	e44e37e5aeba8628556020d05e1606b28e2faa4f
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	THSD4 PDE4D RGPD8 ZSWIM6 JMJD1C ATXN1 NFAT5	7.86e-06	193	165	7	779276e775cb2492e8dd36436295a536084a6415
ToppCell	Bronchial_Brush-Epithelial-Basal_1\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	THSD4 FRAS1 NCKAP5 PTPRZ1 TET1 BCAM CDH13	8.98e-06	197	165	7	f5d87824c0020c95d89e069fd9f70b49e5d5fcea
ToppCell	Bronchus_Control_(B.)\|World / Sample group, Lineage and Cell type	MUC16 ITGA2 NRARP SERPINB13 PTPRZ1 FUT2 MUC4	8.98e-06	197	165	7	b6dff2ee108813e18657e2d8cf850e2423f8c8e9
ToppCell	Bronchial-10x5prime-Stromal-Mesofibroblastic-Mesothelia\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FRAS1 VTN PCDHGB2 SLC30A1 SEZ6L2 SULF1 CPXM1	8.98e-06	197	165	7	26888af95a7cc082a1f1218af35b1f07cb9436ed
ToppCell	Bronchial-10x5prime-Stromal-Mesofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FRAS1 VTN PCDHGB2 SLC30A1 SEZ6L2 SULF1 CPXM1	8.98e-06	197	165	7	438de7f0d35d81d5f5e41dcef7b2c54b6da03df4
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	FAT4 IL16 SDK2 PDE4D ITGA2 VCAN TNFRSF19	8.98e-06	197	165	7	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	Biopsy_IPF-Epithelial-AT1\|Biopsy_IPF / Sample group, Lineage and Cell type	UNC13B NCKAP5 ITGB6 ADRB2 CGN BCAM TNS1	9.28e-06	198	165	7	75bdecbe111fededf6082b11de18b84ca308ef6d
ToppCell	21-Trachea-Epithelial-Club-like_secretory\|Trachea / Age, Tissue, Lineage and Cell class	ATP6V1B1 MACC1 MUC16 BMP3 VCAN FUT2 MUC4	9.28e-06	198	165	7	e735d82e5151c98b5724c543f8ad633c8ed824d2
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ITGA2 ITGB6 SERPINB13 PTPRZ1 BCAM MUC4 CDH13	9.28e-06	198	165	7	5374b0e98d669f36a0571d3c006c7bd5e3c8e87f
ToppCell	Control_saline\|World / Treatment groups by lineage, cell group, cell type	UNC13B FRAS1 NCKAP5 KIDINS220 TJP1 BCAM CDH13	9.59e-06	199	165	7	11c9c1779caceb725ecccf3f23b7d4e6dbd1af64
ToppCell	PSB-critical-LOC-Epithelial-Basal\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ITGA2 NRARP SERPINB13 PTPRZ1 SULF1 BCAM TNS1	9.59e-06	199	165	7	2add64c3e4cb6384ec381f34c3f1f77e13e3f27c
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 FLNB FAT4 ANK1 SULF1 BCAM CDH13	9.59e-06	199	165	7	6a2943a23fdd2ec814662db7c21a0d6804a6cbbc
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal-Suprabasal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 ITGA2 ADARB2 NRARP SERPINB13 PTPRZ1 MUC4	9.59e-06	199	165	7	f5c3561744e2a0e7716657cb521acb1d8f054b41
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE4D ITGA2 MTMR10 ITGB6 TNFRSF19 BCAM NFAT5	9.59e-06	199	165	7	3cd6383c50ce342fe5c175e2e50784d634a90e80
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SDK2 OVOS2 NCKAP5 ADARB2 PTPRZ1 NID1 ATP11C	9.91e-06	200	165	7	c74bc12e13d002dedaaf75a2244ec111e47524e1
ToppCell	NS-control-d_0-4-Epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MACC1 MUC16 ITGA2 TJP1 CGN FUT2 MUC4	9.91e-06	200	165	7	d014959891893b6d3854a471fba1dc50c6625a0a
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SDK2 OVOS2 NCKAP5 ADARB2 PTPRZ1 NID1 ATP11C	9.91e-06	200	165	7	ead9eb579bb25fde05fc15602e3d05ab6617f7ac
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-TNFAIP8L3-L1-2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SDK2 RADX OVOS2 ADARB2 BMP3 PTPRZ1 ATP11C	9.91e-06	200	165	7	978dfb3c1d5e1c3d778a089175c50b8b719626c0
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	FAT4 FRAS1 SDK2 COL6A5 ITGA2 NID1 CDH13	9.91e-06	200	165	7	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	FAT4 FRAS1 SDK2 COL6A5 ITGA2 NID1 CDH13	9.91e-06	200	165	7	a510deaada669e690329183e18df02870bd204b3
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_basal-Basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 ITGA2 SERPINB13 PTPRZ1 BCAM MUC4 CDH13	9.91e-06	200	165	7	9da214f756a03516eaafde00289b90f69623b9f3
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPAMD8 FAT4 IL16 STARD9 VCAN NID1 TNS1	9.91e-06	200	165	7	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-TNFAIP8L3\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SDK2 RADX OVOS2 ADARB2 BMP3 PTPRZ1 ATP11C	9.91e-06	200	165	7	d28b27776c46054b01bdd1e0f1db7c5cd5a48b88
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 ITGA2 NRARP SERPINB13 PTPRZ1 FUT2 MUC4	9.91e-06	200	165	7	ce969c958a31145bbfe315a9a865d7900ecc9549
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MUC16 ITGA2 TJP1 PTPRZ1 CGN BCAM MUC4	9.91e-06	200	165	7	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FAT4 FRAS1 SDK2 COL6A5 ITGA2 NID1 CDH13	9.91e-06	200	165	7	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7-Slc17a8.Syt6-Lancl3_(Cortical_Subplate_pyramidal_cells)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	MACC1 COL6A5 ITGA2 CFAP70 SLC24A1	1.91e-05	88	165	5	fcc15c5c30517c63a835b28627c5f779d9bcd17e
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7-Slc17a8.Syt6-Lancl3_(Cortical_Subplate_pyramidal_cells)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	MACC1 COL6A5 ITGA2 CFAP70 SLC24A1	1.91e-05	88	165	5	7838c65160cf81c02b923fc34f566c0610c8d81b
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3\|E16.5-samps / Age Group, Lineage, Cell class and subclass	LRCH2 PCDHGB2 EFTUD2 VCAN WDR90 CNTN2	1.98e-05	149	165	6	651494e84be03dc7b061ebdfa91756a1c507b9b4
ToppCell	Dendritic_Cells-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	FLNB IL16 ZNF366 RGPD1 SLX4 DSE	2.13e-05	151	165	6	e089bf197ed60e7243160521d4390d4b40a3832b
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FAT4 CPS1 ADARB2 PTPRZ1 VCAN ATP11C	2.21e-05	152	165	6	8ff5a178a8f3550d89a003c0858820aab3773386
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POM121L2 COL6A5 FAM135B NID1 MUC4 HYDIN	2.47e-05	155	165	6	8fdda4e3657ac56188ae88ed3caf145f4d9d1567
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 COL6A5 CPS1 PTPRZ1 SULF1 HYDIN	2.95e-05	160	165	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 COL6A5 CPS1 PTPRZ1 SULF1 HYDIN	2.95e-05	160	165	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	Monocytes-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	PRDM10 FAM106A LPAR6 VCAN	3.25e-05	49	165	4	bf67f5dee042fd680c661db637fde715e48b14c5
ToppCell	368C-Myeloid-Dendritic-cDC1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	FLNB ITGA2 WDFY4 EML3 SLX4 IL17RB	3.28e-05	163	165	6	299ac2463b7f58eee419d822a2a2d64b973d87e9
ToppCell	343B-Myeloid-Macrophage-FABP4+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	SDK2 RGPD8 ZC3H10 VCAN TNS1 TBCE	3.63e-05	166	165	6	f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2
ToppCell	Basal_cells-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	FRAS1 SDK2 ITGA2 SERPINB13 PTPRZ1 CNTN2	3.63e-05	166	165	6	aea2ae12e4746149ebc6da063ef694381c098f80
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DMGDH MOGAT1 UGT3A1 SLC22A18 TMEM174 FGA	3.88e-05	168	165	6	b14fd50232887b6dca1f39014d43c6f66e5c3b5c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 LRCH2 SPEG SULF1 IZUMO1 CDH13	4.01e-05	169	165	6	c7fc3a8c44f07c557b60d469717b66e2f5863d38
ToppCell	10x3'2.3-week_12-13-Myeloid_DC-DC-DC1\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ZHX3 SDK2 RGPD8 ZNF366 WDFY4 DSE	4.28e-05	171	165	6	04346d4eb726875e3537e215ea081a0318ca4ddd
ToppCell	facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IL16 ZBTB2 WDR53 N4BP2 CD40LG TBCE	4.28e-05	171	165	6	f1fdc0ec3399ed6955976d02be7e5fc329a64276
ToppCell	356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	PBX4 NLRP3 SLC22A18 CILP2 CD40LG DSE	4.28e-05	171	165	6	bdd30100b74e012eec3090799c22635aa57fa91d
ToppCell	facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC13B NCKAP5 CILP2 OTOGL N4BP2 IZUMO1	4.43e-05	172	165	6	f2c17c49b375b28ad47dc6cabda62f1c238023dd
ToppCell	facs-Heart-LV-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC13B NCKAP5 CILP2 OTOGL N4BP2 IZUMO1	4.43e-05	172	165	6	6ab4f01098dddb789df298ddf97b3c384405ee6c
ToppCell	Leuk-UTI-Myeloid-cDC1\|Leuk-UTI / Disease, Lineage and Cell Type	ZNF366 NCKAP5 IDH3A WDFY4 NRARP DSE	4.57e-05	173	165	6	226bb8d881f32d65c60f5e4c034c6d465f8e7ba5
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MACC1 MUC16 SERPINB13 PTPRZ1 FUT2 MUC4	4.72e-05	174	165	6	9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZHX3 FAT4 LRCH2 NID1 TNS1 DSE	4.87e-05	175	165	6	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	TCGA-Colorectal-Recurrent_Tumor\|TCGA-Colorectal / Sample_Type by Project: Shred V9	DMGDH VTN INHBC UGT3A1 FGA FOLH1B	4.87e-05	175	165	6	7f74961436f88c0e380819095e6104489914d765
ToppCell	TCGA-Colorectal-Recurrent_Tumor-Colorectal_Adenocarcinoma\|TCGA-Colorectal / Sample_Type by Project: Shred V9	DMGDH VTN INHBC UGT3A1 FGA FOLH1B	4.87e-05	175	165	6	bee8f31f036dfcf9fc6ed29156554771a9ee3c60
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PBX4 FAM135B PTPRZ1 VCAN CPXM1 DSE	4.87e-05	175	165	6	d67c77eee979ad029e7545f383326f0ff77c6e5f
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PBX4 FAM135B PTPRZ1 VCAN CPXM1 DSE	4.87e-05	175	165	6	1d1cdbf3221b03e24eae38afd57cbd6736b37a53
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Neuronal\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	SEZ6L2 KIDINS220 PTPRZ1	5.27e-05	20	165	3	383fa9245ad41596b085fe4c33dc8e910f43538a
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	THSD4 FRAS1 MUC16 CILP2 SULF1 CPXM1	5.36e-05	178	165	6	bcbdd45a2307f8aea14122fa0144b96b1f6eec48
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	THSD4 FRAS1 MUC16 CILP2 SULF1 CPXM1	5.36e-05	178	165	6	c413861148129be1ee94f2ceb5999840217eebe5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 MTMR10 BCAM NFAT5 HYDIN SLX4	5.36e-05	178	165	6	c20f050344a2e120e685e2a7fe36c6dfc1dc37b6
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	UNC13B THSD4 MACC1 NCKAP5 ITGB6 CGN	5.52e-05	179	165	6	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SDK2 POM121L2 BMP3 CPXM1 NID1 TNS1	5.52e-05	179	165	6	b559f5a72cc9e3e35d05cb539b5c2e006e56e652
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	THSD4 SPEG SULF1 VCAN TNS1 CDH13	5.70e-05	180	165	6	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 MACC1 FRAS1 PDE4D TET1 FGA	5.70e-05	180	165	6	023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT4 SDK2 ANK1 OVOS2 NCKAP5 ADARB2	5.70e-05	180	165	6	b6efdb4d319ef6f87f559acd974e5a71b06a2322
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LRCH2 ADARB2 OTOGL STARD9 NID1 TNS1	5.88e-05	181	165	6	451b87ac95154bb80018b8dd245b4a6389d81411
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 MACC1 MTMR10 ITGB6 NFAT5 HYDIN	5.88e-05	181	165	6	6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT4 OVOS2 NCKAP5 SEZ6L2 ADARB2 ATP11C	5.88e-05	181	165	6	2f3d04d22d4ac016e61709ea5af3d48885c946c4
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT4 ANK1 OVOS2 ADARB2 PTPRZ1 CDH13	6.06e-05	182	165	6	d3a037268f026eb2f84428b1821022503cef7756
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLNB NRARP TJP1 SULF1 TNS1 CDH13	6.06e-05	182	165	6	c7f2d24697affa530b748ab32b1d40bdc1bdc20a
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLNB NRARP TJP1 SULF1 TNS1 CDH13	6.06e-05	182	165	6	d95635b74e8cd8bc00bfe40340806b59fb9bee43
ToppCell	367C-Myeloid-Dendritic-cDC1\|367C / Donor, Lineage, Cell class and subclass (all cells)	ZNF366 NCKAP5 WDFY4 NLRP3 NRARP DSE	6.06e-05	182	165	6	6f5228ac47f9ab46d165740cf2655b5ba217acbe
ToppCell	Adult-Epithelial-basal_cell\|Adult / Lineage, Cell type, age group and donor	FRAS1 SDK2 ITGA2 PM20D2 PTPRZ1 SULF1	6.24e-05	183	165	6	00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81
Disease	bilirubin measurement	ZHX3 FAT4 ANK1 PBX4 CPS1 JMJD1C NLRP3 SHKBP1 SLC22A18 CILP2 PTPN11 MIP MYDGF FUT2	9.15e-08	442	154	14	EFO_0004570
Disease	alkaline phosphatase measurement	ZHX3 MACC1 INHBC ZNF366 PBX4 CPS1 SLC30A1 JMJD1C NLRP3 MED24 CILP2 PTPN11 ZNF45 IZUMO1 BCAM FUT2 NFAT5 MFSD13A	6.33e-06	1015	154	18	EFO_0004533
Disease	glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) measurement	RGPD1 CPS1 PRDM10	7.66e-06	8	154	3	EFO_0800533
Disease	fibrinogen measurement	PCSK2 CPS1 JMJD1C NLRP3 PRR12 FGA	2.38e-05	109	154	6	EFO_0004623
Disease	corneal resistance factor	ZHX3 ITGA2 MTMR10 ATXN1 TJP1 VCAN TET1 ARNT2 LRP6 CPXM1 TNS1	2.67e-05	451	154	11	EFO_0010067
Disease	response to hydrochlorothiazide, fasting blood glucose measurement	MOGAT1 VTA1 ADARB2 OTOGL	9.82e-05	46	154	4	EFO_0004465, EFO_0005202
Disease	neutrophil count, basophil count	ZNF366 VTA1 MAST2 JMJD1C NLRP3 ADRB2 ATXN1	1.83e-04	224	154	7	EFO_0004833, EFO_0005090
Disease	granulocyte count	ZNF366 MAST2 JMJD1C NLRP3 MED24 ADRB2 ATXN1	3.91e-04	254	154	7	EFO_0007987
Disease	blood nickel measurement	PDE4D MUC16 VTA1 NLRP3 TNS1	4.27e-04	120	154	5	EFO_0007583
Disease	lung carcinoma, family history of lung cancer	PCSK2 ADARB2 PM20D2	4.61e-04	29	154	3	EFO_0001071, EFO_0006953
Disease	Bleeding tendency	PTPN11 SMAD4	5.59e-04	7	154	2	C1458140
Disease	pentachlorophenol measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022071
Disease	parathion measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022070
Disease	potassium chromate measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022072
Disease	mercuric chloride measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022068
Disease	heptachlor epoxide measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022067
Disease	methoxychlor measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022069
Disease	4,6-dinitro-o-cresol measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022053
Disease	2,4,5-trichlorophenol measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022052
Disease	azinphos methyl measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022055
Disease	aldrin measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022054
Disease	dicofol measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022060
Disease	disulfoton measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022062
Disease	dieldrin measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022061
Disease	endrin measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022064
Disease	endosulfan measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022063
Disease	heptachlor measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022066
Disease	ethion measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022065
Disease	chlorpyrifos measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022057
Disease	cadmium chloride measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022056
Disease	diazinon measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022059
Disease	dibutyl phthalate measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0022058
Disease	environmental exposure measurement	PDE4D MUC16 NLRP3 TNS1	5.87e-04	73	154	4	EFO_0008360
Disease	DDT metabolite measurement	PDE4D MUC16 NLRP3 TNS1	6.18e-04	74	154	4	EFO_0007886
Disease	internet addiction disorder	FLNB ANK1 NID1	6.78e-04	33	154	3	EFO_0803368
Disease	Disproportionate short stature	FLNB PTPN11 SULF1 TBCE	7.18e-04	77	154	4	C0878659
Disease	urticaria (is_implicated_in)	NLRP3 ADRB2	7.42e-04	8	154	2	DOID:1555 (is_implicated_in)
Disease	breast cancer anti-estrogen resistance protein 3 measurement	VTN JMJD1C	7.42e-04	8	154	2	EFO_0008040
Disease	periodontal disease (biomarker_via_orthology)	IL16 CD40LG	7.42e-04	8	154	2	DOID:3388 (biomarker_via_orthology)
Disease	retinal detachment, retinal break	CPAMD8 FRAS1 BMP3	8.07e-04	35	154	3	EFO_0005773, EFO_0010698
Disease	ascending aortic diameter	THSD4 FLNB JMJD1C HYDIN CDH13	8.59e-04	140	154	5	EFO_0021787
Disease	urate measurement	ATP6V1B1 HDAC5 INHBC GON4L CPS1 JMJD1C ITGB6 MEPE TMEM174 PTPN11 NID1 NFAT5 CNTN2	8.67e-04	895	154	13	EFO_0004531
Disease	cervical cancer (is_marker_for)	MACC1 PTPN11 SMAD4	8.77e-04	36	154	3	DOID:4362 (is_marker_for)
Disease	neutrophil count	CELF5 FLNB CPAMD8 MOSPD2 ZNF366 VTA1 CPS1 MAST2 JMJD1C NLRP3 MED24 KIDINS220 ADRB2 ATXN1 CGN MFSD13A HYDIN	9.22e-04	1382	154	17	EFO_0004833
Disease	systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus	FLNB PRR12 PTPN11	1.03e-03	38	154	3	EFO_0000685, EFO_0000717, EFO_0000783, MONDO_0007915
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	DMGDH VTN JMJD1C PTPN11 BCAM NFAT5	1.13e-03	222	154	6	EFO_0008317, EFO_0020943
Disease	cholelithiasis	CPS1 JMJD1C FUT2 NFAT5	1.18e-03	88	154	4	EFO_0004799
Disease	smoking status measurement, chronic obstructive pulmonary disease	THSD4 POM121L2 MED24 TNS1	1.18e-03	88	154	4	EFO_0000341, EFO_0006527
Disease	phospholipids:total lipids ratio	DMGDH VTN INHBC JMJD1C NCOA5 BCAM	1.27e-03	227	154	6	EFO_0020946
Disease	sleep duration, low density lipoprotein cholesterol measurement	ZHX3 PBX4 OGDH BCAM	1.34e-03	91	154	4	EFO_0004611, EFO_0005271
Disease	glutamine measurement, amino acid measurement	CPS1 MIP	1.44e-03	11	154	2	EFO_0005134, EFO_0009768
Disease	gastrin-releasing peptide measurement	VTN JMJD1C	1.44e-03	11	154	2	EFO_0022000
Disease	Crohn's disease of large bowel	VTN NLRP3 FUT2	1.58e-03	44	154	3	C0156147
Disease	IIeocolitis	VTN NLRP3 FUT2	1.58e-03	44	154	3	C0949272
Disease	Crohn's disease of the ileum	VTN NLRP3 FUT2	1.58e-03	44	154	3	C0267380
Disease	Regional enteritis	VTN NLRP3 FUT2	1.58e-03	44	154	3	C0678202
Disease	fibrinogen measurement, tissue plasminogen activator measurement	CPS1 JMJD1C NLRP3	1.68e-03	45	154	3	EFO_0004623, EFO_0004791
Disease	fibrinogen measurement, plasminogen activator inhibitor 1 measurement	CPS1 JMJD1C NLRP3	1.68e-03	45	154	3	EFO_0004623, EFO_0004792
Disease	endometrial carcinoma (is_implicated_in)	CDH13 SMAD4	1.73e-03	12	154	2	DOID:2871 (is_implicated_in)
Disease	blood cobalt measurement	PDE4D MUC16 NLRP3 TNS1	1.97e-03	101	154	4	EFO_0007577
Disease	sodium measurement	MAST2 JMJD1C ADRB2 NFAT5	2.11e-03	103	154	4	EFO_0009282
Disease	response to fenofibrate	JMJD1C FAM135B CDH13	2.28e-03	50	154	3	GO_1901557
Disease	Crohn Disease	VTN NLRP3 FUT2	2.28e-03	50	154	3	C0010346
Disease	gallstones	CPS1 JMJD1C FUT2 NFAT5	2.51e-03	108	154	4	EFO_0004210
Disease	blood urea nitrogen measurement	GON4L CPS1 TMEM174 MIP IZUMO1 WDR90 FUT2 NFAT5	2.66e-03	452	154	8	EFO_0004741
Disease	Familial thoracic aortic aneurysm and aortic dissection	PLOD3 VCAN SMAD4	2.70e-03	53	154	3	C4707243
Disease	cancer biomarker measurement	FAM135B FUT2	2.72e-03	15	154	2	EFO_0005127
Disease	thrombosis (is_implicated_in)	VTN ITGA2	2.72e-03	15	154	2	DOID:0060903 (is_implicated_in)
Disease	susceptibility to common cold measurement	IL16 ANKRD27 FUT2	2.85e-03	54	154	3	EFO_0008417
Disease	forced expiratory volume	THSD4 DMGDH ANK1 POM121L2 VTA1 JMJD1C EML3 ADRB2 SULF1 NFAT5 TNS1	2.96e-03	789	154	11	EFO_0004314
Disease	serum non-albumin protein measurement	ZNF366 UGT3A1 CPS1 MAST2 NLRP3 PTPN11 FUT2	2.96e-03	361	154	7	EFO_0004568
Disease	Ischemic stroke, fibrinogen measurement	CPS1 JMJD1C NLRP3	3.00e-03	55	154	3	EFO_0004623, HP_0002140
Disease	DiGeorge Syndrome	ESS2 JMJD1C	3.10e-03	16	154	2	C0012236
Disease	CONOTRUNCAL ANOMALY FACE SYNDROME	ESS2 JMJD1C	3.10e-03	16	154	2	C0795907
Disease	ureidopropionic acid measurement	CPS1 ADARB2	3.10e-03	16	154	2	EFO_0010542
Disease	Blood Coagulation Disorders	PTPN11 SMAD4	3.10e-03	16	154	2	C0005779
Disease	Idiopathic pulmonary arterial hypertension	HDAC5 SMAD4	3.10e-03	16	154	2	C3203102
Disease	Shprintzen syndrome	ESS2 JMJD1C	3.10e-03	16	154	2	C0220704
Disease	Drug habituation	THSD4 ZNF366 ADARB2 CDH13	3.15e-03	115	154	4	C0013170
Disease	Drug abuse	THSD4 ZNF366 ADARB2 CDH13	3.15e-03	115	154	4	C0013146
Disease	Prescription Drug Abuse	THSD4 ZNF366 ADARB2 CDH13	3.15e-03	115	154	4	C4316881
Disease	Substance-Related Disorders	THSD4 ZNF366 ADARB2 CDH13	3.15e-03	115	154	4	C0236969
Disease	Drug Use Disorders	THSD4 ZNF366 ADARB2 CDH13	3.15e-03	115	154	4	C0013222
Disease	Drug Dependence	THSD4 ZNF366 ADARB2 CDH13	3.15e-03	115	154	4	C1510472
Disease	Substance Dependence	THSD4 ZNF366 ADARB2 CDH13	3.15e-03	115	154	4	C0038580
Disease	Substance Use Disorders	THSD4 ZNF366 ADARB2 CDH13	3.15e-03	115	154	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	THSD4 ZNF366 ADARB2 CDH13	3.15e-03	115	154	4	C0029231
Disease	ovarian cancer (is_implicated_in)	MUC16 CDH13 SMAD4	3.16e-03	56	154	3	DOID:2394 (is_implicated_in)
Disease	Substance abuse problem	THSD4 ZNF366 ADARB2 CDH13	3.25e-03	116	154	4	C0740858
Disease	triglycerides to total lipids in small VLDL percentage	DMGDH JMJD1C BCAM	3.49e-03	58	154	3	EFO_0022338
Disease	fibrinogen measurement, factor VII measurement	CPS1 JMJD1C NLRP3	3.49e-03	58	154	3	EFO_0004619, EFO_0004623
Disease	erythritol measurement	MAST2 ITGB6	3.50e-03	17	154	2	EFO_0021171
Disease	sphingomyelin 14:0 measurement	PDE4D NID1	3.50e-03	17	154	2	EFO_0010390
Disease	Familial primary pulmonary hypertension	HDAC5 SMAD4	3.50e-03	17	154	2	C0340543
Disease	perinatal necrotizing enterocolitis (biomarker_via_orthology)	TJP1 CD40LG	3.50e-03	17	154	2	DOID:8677 (biomarker_via_orthology)
Disease	triglycerides to total lipids in small LDL percentage	DMGDH JMJD1C BCAM	3.66e-03	59	154	3	EFO_0022337
Disease	Alzheimer disease, polygenic risk score	FRAS1 PCDHGB2 ZNF366 ZSWIM6 MAST2 ZNF45 BCAM NFAT5 HYDIN	3.77e-03	586	154	9	EFO_0030082, MONDO_0004975
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	DMGDH CPS1 JMJD1C BCAM	3.78e-03	121	154	4	EFO_0008595, EFO_0020943
Disease	monocyte count	FLNB ZBTB2 ANK1 INHBC ZNF366 GON4L PBX4 IQCN MAST2 OGDH MED24 CILP2 ATXN1 VCAN MYDGF	3.91e-03	1320	154	15	EFO_0005091
Disease	acute pancreatitis	RADX ADRB2	3.92e-03	18	154	2	EFO_1000652

Protein segments in the cluster

Peptide	Gene	Start	Entry
VSSLQGHRNFPTGTV	BMP3	256	P12645
DFVGHQGTVPSDNID	ADRB2	386	P07550
TTEHSSIHQPGVQEG	VCAN	1806	P13611
SVFVNVTDPSQVSHG	CD40LG	236	P29965
NTFGQLGHSDFPTTV	ALS2	586	Q96Q42
GSANAESVQGVTPLH	ANK1	626	P16157
ETGNHDSFPGAVVSI	FAM106A	111	Q4KMX7
GPLNGASEVTFSVHV	FAT4	2526	Q6V0I7
VDAGHPTRFSGVITQ	CPXM1	176	Q96SM3
SHSPGVAVIQFAVGE	ATXN1	621	P54253
TIINGNPGQSFEIHT	CDH13	401	P55290
VNGTFIIHPDSGNLT	CDHR5	296	Q9HBB8
VRHQSFVLVGETGSG	DHX15	151	O43143
AFSSSVVHVPGVNDI	ARNT2	536	Q9HBZ2
HVNPAVTFAFLVGSQ	MIP	66	P30301
QGSQTFHGAPLTVAT	RANBP2	856	P49792
SGFVPNVVHSSEEVV	RAB39B	191	Q96DA2
AVVGPSHEVQEQSSG	QSER1	961	Q2KHR3
SQTGPVHAPVFAVAV	ADARB2	146	Q9NS39
QGSQTFHGAPLTVAT	RGPD5	856	Q99666
QGSQTFHGAPLTVAT	RGPD8	856	O14715
VAAGTPNTSGSIHEN	IQCN	536	Q9H0B3
TNESGVFITGHRGQP	RADX	461	Q6NSI4
GVNVTSQDGSSPLHV	ANKRD27	736	Q96NW4
GPSVLRHAQQGGFSV	EXO5	251	Q9H790
RIIQAHGGTVDPTFT	PAXIP1	631	Q6ZW49
SGGFIGFATTIHQIV	PLOD3	166	O60568
GTHVVVGSIFTNATP	MMADHC	271	Q9H3L0
THGASLVPVVSFGEN	MOGAT1	216	Q96PD6
IGESTAGPTTHQFAV	MUC16	591	Q8WXI7
FHTQQSEGAETTGRP	MUC4	451	Q99102
ETGNHDSFPGAVVSI	FAM106C	111	P0CH98
QIFGARHLSPTETDG	KIDINS220	421	Q9ULH0
HTPVVAGTSRGFQAQ	FRAS1	3301	Q86XX4
VFISHSNVGIGTIVG	SLC24A1	516	O60721
IQTGFAGPSEAESTH	MEPE	281	Q9NQ76
SFGPEGQTALHQSVI	NRARP	46	Q7Z6K4
PEAQISLGGSITAFH	MTMR10	666	Q9NXD2
AQSSVILGGAAHRPF	INHBC	206	P55103
GSETGANHISPFLSQ	JMJD1C	721	Q15652
IQHSTIIGFSQVFEP	IL17RB	211	Q9NRM6
FTVDSRPLTQVGGDH	FLNB	1251	O75369
VVDNGDGTHTVTYTP	FLNB	1471	O75369
VGDTASFSVTVNIPH	ITGB6	411	P18564
TNHGAAGVPFASDTI	PCDHGB2	791	Q9Y5G2
SPGSGLILQANFVHS	PDE4D	171	Q08499
FTRQAEVTFVGHPGN	NID1	516	P14543
SRGGSPFAIVITQQH	NCOA5	246	Q9HCD5
QSGAAVVHETVRSFG	FOLH1B	81	Q9HBA9
VHRVFPNGLASQEGT	IL16	1141	Q14005
GSGSQFVVTAQIAHP	LRP6	391	O75581
GPSIDVQSFTVHGDS	DSE	666	Q9UL01
FSTTIHVPNIATGEQ	NSF	661	P46459
QNHGFPLGSTVQSET	GBP6	61	Q6ZN66
GGSAPAVFVQSTHSQ	LPAR6	146	P43657
AAQVHFVPDTGTVAQ	PRDM10	21	Q9NQV6
QSHPGDFVLSVRTGD	PTPN11	141	Q06124
SAIPVHDSVGVTYQG	PTPRZ1	946	P23471
TFHVAVIVTEFGTGN	OVOS2	296	Q6IE36
TISPNSFFHINISGG	PCDHB10	171	Q9UN67
TGESTHFVAGAPRAN	ITGA2	446	P17301
VVTNAGRSHDVQPFT	NFAT5	526	O94916
HIGNVASSVPVENFT	OGDH	616	Q02218
ASSVPVENFTIHGGL	OGDH	621	Q02218
TAVDTTEVGVPGNHA	PBX4	286	Q9BYU1
IDFCPGQNVSGVTTH	GALNS	416	P34059
ATFETPEVHAGTGVV	ESS2	106	Q96DF8
FGHPSSVAGEVVFNT	CPS1	61	P31327
NGVAIFESVHGTAPD	IDH3A	281	P50213
HVFGSGTQLTVLSQP	IGLL1	96	P15814
VPANGEVTLQVHFSS	HYDIN	2746	Q4G0P3
FSPIDSTVDVGQSVH	HYDIN	4256	Q4G0P3
IGVTHVPVGASFASN	BICRAL	166	Q6AI39
HLVSGQTFAASGSPV	BICRAL	471	Q6AI39
EGTVSFLPAQHTVGS	CERK	326	Q8TCT0
EIHTLQETVGFGNPS	CFAP70	1106	Q5T0N1
QVNGSRPGTFVGVHV	FUT2	186	Q10981
VVGFDISTHVQGQPL	COL6A5	1196	A8TX70
EGPLFHNQTSVTVDG	CPAMD8	111	Q8IZJ3
TVAETLHPAFSGVQQ	CELF5	351	Q8N6W0
PSHGRVAGFEVQSLQ	GON4L	51	Q3T8J9
VVRGSGHVTVFGLSN	CHIC2	31	Q9UKJ5
FIPTDGRHFVSQTTG	CNTN2	176	Q02246
HPDGTIQVSNGSLAF	CAPRIN2	826	Q6IMN6
VPQGHVAVGEFQEVS	MACC1	236	Q6ZN28
LQTHPSGTQSGIFNI	FGA	636	P02671
EETGQVVGFHQPGSI	DMGDH	121	Q9UI17
VVGFHQPGSIRLATT	DMGDH	126	Q9UI17
RVTPDAVHSVGGNSS	MAST2	1281	Q6P0Q8
GSVNSSPATIINFHV	IZUMO1	236	Q8IYV9
FHPSGAVVAVGLNTG	EML3	646	Q32P44
VHGVLNGVAPSSATN	SDR39U1	211	Q9NRG7
ITHQPLGSFGVVSTH	FAM135B	1066	Q49AJ0
HSTIAENGFTGSVPN	HDAC5	326	Q9UQL6
HFGTVSPQTSQAGVA	BCAM	536	P50895
VAQNGGAETSHTEPV	SCAF4	641	O95104
RPNFQDSIHVGFVSG	SDK2	846	Q58EX2
TVGSGPQLFQTFTVH	KCTD3	406	Q9Y597
GHDLFQQSLITPVGS	MFSD13A	431	Q14CX5
VPEQGNAHIGSFVSF	LRCH2	416	Q5VUJ6
GQHGVPIDFRTQISF	OTOGL	726	Q3ZCN5
QGSQTFHGAPLTVAT	RGPD1	841	P0DJD0
SVAPHETQTQRGGEF	RNF180	296	Q86T96
GRTPLHFAVADGNVT	INVS	221	Q9Y283
SEPVHTVVFQGAAGI	NLRP3	216	Q96P20
VSPHGGLTVSAQDRF	MOSPD2	391	Q8NHP6
HPFVLQSVGGQTLTV	GTF2F2	81	P13984
VHFTLPDGTQRSGQV	ATP6V1B1	66	P15313
GEPIEFSSHQTGVVT	NCKAP5	676	O14513
RGTFGGNIIQHSIPA	TAF1	581	P21675
GAFSQVTLHATAQAP	PKDREJ	656	Q9NTG1
FEGQPSLSTEGHSIQ	SMAD4	166	Q13485
ILGSRTAGPHTQFVQ	MED24	911	O75448
GIAPVGFSQHETVDS	RHBDF1	426	Q96CC6
THVGFPENLTNGATA	POTEJ	511	P0CG39
VGSGPQLFQTFTVHR	SHKBP1	416	Q8TBC3
QFQTGIVSDHPAEAG	SIGLEC6	401	O43699
RTASDAGFPVGSHVQ	SEZ6L2	716	Q6UXD5
SPTRHGFLGAGVVSQ	STARD9	4536	Q9P2P6
HTFPQLQVEQSGEGS	PRR12	1911	Q9ULL5
QARGVHQSVATDGPS	NDUFS7	26	O75251
GITHEQRAGSFSTVP	PI4KB	436	Q9UBF8
VSQNVDGLHVRSGFP	SIRT6	111	Q8N6T7
RIVIQTHQSGAFGSV	POM121L2	866	Q96KW2
STDFGNVSFVVPGIH	PM20D2	351	Q8IYS1
FGVPVFGHVQVAINT	SLC22A18	391	Q96BI1
PSRAGVHAQQEATTG	SLX4	1636	Q8IY92
TTSFLGQAFGAIPHQ	TET1	361	Q8NFU7
VPGGNSTLRVAIHNF	CCDC15	926	Q0P6D6
HGVQIRFITEPVSGA	CGN	16	Q9P2M7
TVATSDAHGTFRVPG	CILP2	236	Q8IUL8
TFAVQVHSPVPSEAG	CNK3/IPCEF1	701	G9CGD6
GTRTVFVGNHPVSET	ATP11C	21	Q8NB49
GVGTRHVQEFISGQS	RNF149	186	Q8NC42
FHGTGSAVASVAVDP	WDR47	796	O94967
PSIRLFVTHGGQNSV	UGT3A1	361	Q6NUS8
QQVTLTTHAPFGLGA	TMEM223	131	A0PJW6
TGTTFRVLSDHQGAP	WDR90	1556	Q96KV7
VVEGQPASVTVTFNH	SPEG	1401	Q15772
VNGEHATVRFAGVVP	TBCE	16	Q15813
VFGNHSPLERVSGVV	RNF148	61	Q8N7C7
VDVNTGAELTPHQTF	RPN2	421	P04844
IGFTVTSAPGHENVH	SERPINB13	351	Q9UIV8
AEVPHSTGVASNTIQ	VTA1	226	Q9NP79
GALGQHFSQSPRVTV	WDR97	936	A6NE52
QARAQFSVAGVHTVP	TNS1	1161	Q9HBL0
AVGQLGVRVFHSSPA	WDFY4	1351	Q6ZS81
GEVSIQVDLFTHPGT	UNC13B	1421	O14795
TPLGHTRFQGADDVT	WDR53	41	Q7Z5U6
NGQAVHGELSPVTDF	U2AF1L4	136	Q8WU68
HQGLSAVATASPGVF	nan	111	Q6ZVQ6
GRDNPHFQSGETSIV	TJP1	41	Q07157
VFTGINQPITFHGAT	TMEM174	121	Q8WUU8
GFHLSGTVTEPAIQS	ZSWIM6	226	Q9HCJ5
GPAAAFAGTVTIHNQ	ZXDA	156	P98168
VPVFQSDGESAQGSH	ZNF366	601	Q8N895
VGGAVPVQSHSENFT	TNFRSF19	356	Q9NS68
HTGVPFTSSQQGESR	ZBTB2	276	Q8N680
GHQDVVRDLSFTPSG	WSB2	151	Q9NYS7
APTVGTVATFNHGIA	ZC3H10	296	Q96K80
GIHATTIQPEFASVG	SLC30A1	411	Q9Y6M5
VGTHGATQSFSQPAR	THSD4	271	Q6ZMP0
PGHVNFSDEVTAGLR	EFTUD2	206	Q15029
REGDHSFINGAVPVS	ZHX3	226	Q9H4I2
EHGGATFINAFVTTP	SULF1	71	Q8IWU6
NATVHEQVGGPSLTS	VTN	86	P04004
FRNVVSVGHQSTPDG	ZNF45	41	Q02386
VFQEGAGTHFPSVRV	nan	186	Q6ZTC4
TVVDGQPGFHSDTLS	YTHDF1	161	Q9BYJ9
SNFVQVTHQGGPVFV	GARIN5B	46	Q8N5Q1
TTVAFDVRPGGVVHS	MYDGF	36	Q969H8
DVRPGGVVHSFSHNV	MYDGF	41	Q969H8
VPEFSHGIGISNADS	N4BP2	1176	Q86UW6
TVPERFHCVGGSVQD	PCSK2	461	P16519